Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Biological Safety Testing Market Research Report 2012-2023

  • HEY2840838
  • 117 Pages
  • December 2018
  • Medical Devices
Download Sample    Get Discount   
 
Summary

The global Biological Safety Testing market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Adventitious Agents Detection Test

Cell Line Authentication and Characterization tests

Bioburden Testing

Endotoxin Tests

Sterility Testing

Residual Host Contaminant Detection Tests

Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Lonza Group

SGS SA

WuXiPharmaTech

BSL Bioservice

Merck KGaA

Cytovance Biologics

Toxikon Corporation

Charles River Laboratories International

Sigma-Aldrich Corporation

Avance Biosciences

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Blood Products

Stem Cell Products

Cellular and Gene Therapy Products

Tissue Products

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 Adventitious Agents Detection Test

1.2.1.2 Cell Line Authentication and Characterization tests

1.2.1.3 Bioburden Testing

1.2.1.4 Endotoxin Tests

1.2.1.5 Sterility Testing

1.2.1.6 Residual Host Contaminant Detection Tests

1.2.1.7 Others

1.2.2 by Application

1.2.2.1 Blood Products

1.2.2.2 Stem Cell Products

1.2.2.3 Cellular and Gene Therapy Products

1.2.2.4 Tissue Products

1.2.2.5 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Adventitious Agents Detection Test Market, 2012-2017

4.1.2 Cell Line Authentication and Characterization tests Market, 2012-2017

4.1.3 Bioburden Testing Market, 2012-2017

4.1.4 Endotoxin Tests Market, 2012-2017

4.1.5 Sterility Testing Market, 2012-2017

4.1.6 Residual Host Contaminant Detection Tests Market, 2012-2017

4.1.7 Others Market, 2012-2017

4.2 Market Forecast

4.2.1 Adventitious Agents Detection Test Market Forecast, 2018-2023

4.2.2 Cell Line Authentication and Characterization tests Market Forecast, 2018-2023

4.2.3 Bioburden Testing Market Forecast, 2018-2023

4.2.4 Endotoxin Tests Market Forecast, 2018-2023

4.2.5 Sterility Testing Market Forecast, 2018-2023

4.2.6 Residual Host Contaminant Detection Tests Market Forecast, 2018-2023

4.2.7 Others Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Blood Products Market, 2012-2017

5.1.2 Stem Cell Products Market, 2012-2017

5.1.3 Cellular and Gene Therapy Products Market, 2012-2017

5.1.4 Tissue Products Market, 2012-2017

5.1.5 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Blood Products Market Forecast, 2018-2023

5.2.2 Stem Cell Products Market Forecast, 2018-2023

5.2.3 Cellular and Gene Therapy Products Market Forecast, 2018-2023

5.2.4 Tissue Products Market Forecast, 2018-2023

5.2.5 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Lonza Group

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 SGS SA

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 WuXiPharmaTech

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 BSL Bioservice

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 Merck KGaA

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 Cytovance Biologics

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Toxikon Corporation

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Charles River Laboratories International

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 Sigma-Aldrich Corporation

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.10 Avance Biosciences

8.10.1 Profile

8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)

9 Conclusion

Table Product Specifications of Biological Safety Testing

Table Products Segment of Biological Safety Testing

Table Adventitious Agents Detection Test Overview

Table Cell Line Authentication and Characterization tests Overview

Table Bioburden Testing Overview

Table Endotoxin Tests Overview

Table Sterility Testing Overview

Table Residual Host Contaminant Detection Tests Overview

Table Others Overview

Table Global Biological Safety Testing Market by Type, 2011-2022 (USD Million)

Table Application Segment of Biological Safety Testing

Table Blood Products Overview

Table Stem Cell Products Overview

Table Cellular and Gene Therapy Products Overview

Table Tissue Products Overview

Table Others Overview

Table Global Biological Safety Testing Market by Application, 2011-2022 (USD Million)

Table Global Biological Safety Testing Market by Region, 2011-2022 (USD Million)

Table Cost of Biological Safety Testing

Table Market Dynamics

Table Policy of Biological Safety Testing

Table GDP of Major Countries

Table Adventitious Agents Detection Test CAGR by Revenue and Volume, 2012-2017

Table Cell Line Authentication and Characterization tests CAGR by Revenue and Volume, 2012-2017

Table Bioburden Testing CAGR by Revenue and Volume, 2012-2017

Table Endotoxin Tests CAGR by Revenue and Volume, 2012-2017

Table Sterility Testing CAGR by Revenue and Volume, 2012-2017

Table Residual Host Contaminant Detection Tests CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

Table Adventitious Agents Detection Test CAGR by Revenue and Volume, 2012-2022

Table Cell Line Authentication and Characterization tests CAGR by Revenue and Volume, 2012-2022

Table Bioburden Testing CAGR by Revenue and Volume, 2012-2022

Table Endotoxin Tests CAGR by Revenue and Volume, 2012-2022

Table Sterility Testing CAGR by Revenue and Volume, 2012-2022

Table Residual Host Contaminant Detection Tests CAGR by Revenue and Volume, 2012-2022

Table Others CAGR by Revenue and Volume, 2012-2022

Table Blood Products CAGR by Revenue and Volume, 2012-2017

Table Stem Cell Products CAGR by Revenue and Volume, 2012-2017

Table Cellular and Gene Therapy Products CAGR by Revenue and Volume, 2012-2017

Table Tissue Products CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450